Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Von Wichmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|January 2, 2017
Quality indicators: A tool to improve efficiencyJosé R Blanco, Miguel A Von Wichmann
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|February 12, 2021
Guide for the screening of HCV infection in Spain, 2020Juan Berenguer, Federico García, Miguel A Von-Wichmann, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 6, 2021
Guide for the screening of HCV infection in Spain, 2020Juan Berenguer, Federico García, Miguel A Von-Wichmann, et al.
AIDS (London, England)|June 6, 2013
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patientsJuan Macías, Angela Camacho, Miguel A Von Wichmann, et al.
AIDS (London, England)|February 19, 2011
The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patientsMaría López-Diéguez, María L Montes, José F Pascual-Pareja, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2011
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis CJuan Macías, Karin Neukam, Joaquín Portilla, et al.
Annals of Hepatology|May 29, 2015
Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patientsTeresa Aldámiz-Echevarría, Juan González-García, Miguel A Von Wichmann, et al.
Hepatology (Baltimore, Md.)|December 30, 2014
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short termJuan Macías, María Mancebo, Manuel Márquez, et al.
Scientific Reports|August 23, 2019
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRLorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2013
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapyJuan Macías, Manuel Márquez, Francisco Téllez, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Enfermedades Infecciosas Y Microbiologia Clinica|January 2, 2017
Quality indicators: A tool to improve efficiencyJosé R Blanco, Miguel A Von Wichmann
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|February 12, 2021
Guide for the screening of HCV infection in Spain, 2020Juan Berenguer, Federico García, Miguel A Von-Wichmann, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 6, 2021
Guide for the screening of HCV infection in Spain, 2020Juan Berenguer, Federico García, Miguel A Von-Wichmann, et al.
AIDS (London, England)|June 6, 2013
Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patientsJuan Macías, Angela Camacho, Miguel A Von Wichmann, et al.
AIDS (London, England)|February 19, 2011
The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patientsMaría López-Diéguez, María L Montes, José F Pascual-Pareja, et al.
The Journal of Antimicrobial Chemotherapy|March 15, 2011
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis CJuan Macías, Karin Neukam, Joaquín Portilla, et al.
Annals of Hepatology|May 29, 2015
Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patientsTeresa Aldámiz-Echevarría, Juan González-García, Miguel A Von Wichmann, et al.
Hepatology (Baltimore, Md.)|December 30, 2014
Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short termJuan Macías, María Mancebo, Manuel Márquez, et al.
Scientific Reports|August 23, 2019
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVRLorena Vigón, Sonia Vázquez-Morón, Juan Berenguer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2013
Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapyJuan Macías, Manuel Márquez, Francisco Téllez, et al.
Pageof 2